Condition
Non-small Cell Lung Cancer|Small Cell Lung Cancer|Mesothelioma|Esophageal Cancer|Gastric Cancer|Liver Cancer|Pancreatic Cancer
Estimated Enrollment: 350
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: No masking|Primary Purpose: Supportive Care
Study ID Numbers: 10-434
Study First Received: July 20, 2011
Last Updated: February 2, 2017
Estimated Primary Completion Date: April 2016
Primary Outcome Measures:
Functional Assessment of Cancer Therapy (Quality of life measure)|Hospital Anxiety and Depression Scale (Mood)|Prognostic Understanding|Family Caregiver Quality of Life (SF-36)|Family Caregiver Hospital Anxiety and Depression Scale (Mood)|Family Caregiver Prognostic Understanding|Resource utilization at the end of life (EOL)|Health Care Costs|Code Status Documentation|Coping (Brief Cope)|FACT-Lung|FACT-hepatobiliary and FACT-espophageal
Sponsors and Collaborators:
Massachusetts General Hospital
Website Link: https://ClinicalTrials.gov/show/NCT01401907